> The radvac vaccine will have serious side effects (i.e. besides stuffy nose for a day) for >50% of people who try it
It should be well below 1%. Firstly, if it were that bad as to cause serious side effects for >50% of people who try it, would the RaDVaC team risk promoting it? Secondly, if it were that bad, wouldn’t we hear bad stories about side effects? Thirdly, getting serious side effects accidentally in >50% cases sounds pretty hard on its own.
> The radvac vaccine induces antibodies detectable in a standard commercial blood test in most people, using the dosage in the paper with 2 booster shots
<1%, because RaDVaC team has tried it and didn’t manage to get any positive result.
> The radvac vaccine induces antibodies detectable in a standard commercial blood test in most people, using “more dakka”, for some reasonable version of “more dakka”
This greatly depends on what “more dakka” and “reasonable version” means. I assume that “reasonable version” implies “doesn’t cause too much harm due to immune system overstimulation”. If “more dakka” means simply a higher dosage, then I think, that this is unlikely (5%), because 1) RaDVaC team experimented on themselves quite a bit, they received a lot of dakka, but no commercial blood test detection, 2) RaDVaC team seems reasonable enough to try this approach if it looked promising. If “more dakka“ includes stronger adjuvants (chitosan is considered a weak, but safe one), then it is much more likely (20%?), because RaDVaC team didn’t investigate those (for a reason) and it sounds plausible that you can get an immune response by irritating the immune system really, really strongly.
> The radvac vaccine will have serious side effects (i.e. besides stuffy nose for a day) for >50% of people who try it
It should be well below 1%. Firstly, if it were that bad as to cause serious side effects for >50% of people who try it, would the RaDVaC team risk promoting it? Secondly, if it were that bad, wouldn’t we hear bad stories about side effects? Thirdly, getting serious side effects accidentally in >50% cases sounds pretty hard on its own.
> The radvac vaccine induces antibodies detectable in a standard commercial blood test in most people, using the dosage in the paper with 2 booster shots
<1%, because RaDVaC team has tried it and didn’t manage to get any positive result.
> The radvac vaccine induces antibodies detectable in a standard commercial blood test in most people, using “more dakka”, for some reasonable version of “more dakka”
This greatly depends on what “more dakka” and “reasonable version” means. I assume that “reasonable version” implies “doesn’t cause too much harm due to immune system overstimulation”. If “more dakka” means simply a higher dosage, then I think, that this is unlikely (5%), because 1) RaDVaC team experimented on themselves quite a bit, they received a lot of dakka, but no commercial blood test detection, 2) RaDVaC team seems reasonable enough to try this approach if it looked promising. If “more dakka“ includes stronger adjuvants (chitosan is considered a weak, but safe one), then it is much more likely (20%?), because RaDVaC team didn’t investigate those (for a reason) and it sounds plausible that you can get an immune response by irritating the immune system really, really strongly.
That’s false, they got several positive anitbody results in ~June or so last year. See a comment elsewhere on this post.
I think he might mean commercial blood antibody tests specifically?
Yes, exactly. “None of us has tested positive using insensitive commercial point-of-care tests”